GLP-1 & MetabolicMW: 4813.5 g/mol
Tirzepatide (Dual GIP / GLP-1 Receptor Agonist)
A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist studied for metabolic homeostasis and adipose regulation.
Biological Mechanism
Synergistically activates both GIP and GLP-1 receptors, delaying gastric emptying, reducing glucagon secretion, and improving insulin sensitivity.
Common Research Dosing
2.5 mg – 15 mg
Reconstitute with ~2 mL BAC water
Storage & Reconstitution
Highly sensitive to heat and light. Keep refrigerated at 2°C–8°C post-reconstitution.
Audited Vendor Rankings
Top Verified Vendors for Tirzepatide
Scientific Context: Tirzepatide (Dual GIP / GLP-1 Receptor Agonist) is referenced strictly for laboratory research, cell culture studies, and in-vitro analytical testing. It is not licensed for human medical or therapeutic use.